Showing results (911-920 of 6,996) with videos related to
Sort By:
Pageof 700
Cancer Science|September 27, 2017
Comprehensive genomic profiling of lung cancer using a validated panel to explore therapeutic targets in East Asian patientsLiping Liu, Jilong Liu, Di Shao, et al.Cancer Science|September 3, 2017
Intersection of retinoblastoma tumor suppressor function, stem cells, metabolism, and inflammationShunsuke Kitajima, Chiaki TakahashiCancer Science|July 15, 2016
Quantitative assessment of chemotherapy-induced peripheral neurotoxicity using a point-of-care nerve conduction deviceAyumu Matsuoka, Ayako Mitsuma, Osamu Maeda, et al.Cancer Science|July 15, 2016
High-dose methotrexate following intravitreal methotrexate administration in preventing central nervous system involvement of primary intraocular lymphomaHiroki Akiyama, Hiroshi Takase, Fumito Kubo, et al.Cancer Science|February 18, 2018
Downregulation of reticulocalbin-1 differentially facilitates apoptosis and necroptosis in human prostate cancer cellsXiaofei Liu, Nianzhao Zhang, Dawei Wang, et al.Cancer Science|February 22, 2018
X-ray-enhanced cancer cell migration requires the linker of nucleoskeleton and cytoskeleton complexHiromasa Imaizumi, Katsutoshi Sato, Asuka Nishihara, et al.Cancer Science|February 24, 2018
Anti-human SIRPα antibody is a new tool for cancer immunotherapyYoji Murata, Daisuke Tanaka, Daisuke Hazama, et al.Cancer Science|March 4, 2018
Phase I study of taselisib in Japanese patients with advanced solid tumors or hormone receptor-positive advanced breast cancerKenji Tamura, Makoto Kodaira, Chikako Shimizu, et al.Cancer Science|March 2, 2018
Prognostic significance of grade 3/4 neutropenia in Japanese prostate cancer patients treated with cabazitaxelTakeo Kosaka, Toshiaki Shinojima, Shinya Morita, et al.Cancer Science|February 26, 2018
Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myelomaShinsuke Iida, Masashi Wakabayashi, Kunihiro Tsukasaki, et al.Pageof 700